Similar articles

• Phase II trial of vindesine in advanced head and neck cancer.

  Cheng E, Young CW, Wittes RE. Cheng E, et al. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1141-2. Cancer Treat Rep. 1980. PMID: 7459901
• Vindesine in the treatment of advanced colorectal cancer: a phase II study.

  Diaz-Rubio E, Martin-Jimenez M. Diaz-Rubio E, et al. Cancer Treat Rep. 1984 Mar;68(3):555-6. Cancer Treat Rep. 1984. PMID: 6704985 No abstract available.
• Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.

  Wong PP, Yagoda A, Currie VE, Young CW. Wong PP, et al. Cancer Treat Rep. 1977 Dec;61(9):1727-9. Cancer Treat Rep. 1977. PMID: 340038 Clinical Trial. No abstract available.
• Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.

  Forastiere AA. Forastiere AA. Semin Oncol. 1993 Aug;20(4 Suppl 3):56-60. Semin Oncol. 1993. PMID: 8102018 Review.
• Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.

  Cersosimo RJ, Bromer R, Licciardello JT, Hong WK. Cersosimo RJ, et al. Pharmacotherapy. 1983 Sep-Oct;3(5):259-74. doi: 10.1002/j.1875-9114.1983.tb03269.x. Pharmacotherapy. 1983. PMID: 6359081 Review.